speb/financial-data huggingface dataset:
SCI balance_sheet (quarterly, 2025-12-31) — Working Capital: -333911000.00
SCI income_statement (annual, 2025-12-31) — Write Off: 3400000.00
SCI income_statement (quarterly, 2025-12-31) — Write Off: 2478000.00
SCI income_statement (quarterly, 2026-03-31) — +Operating Expense: 43911000.00
SCI income_statement (quarterly, 2026-03-31) — +Total Revenue: 1096454000.00
SCI balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 728493000.00
SCI balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 100255000.00
SCI balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 981975000.00
SCI balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -3725000.00
SCI cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 3656000.00
SCI cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 3656000.00
SCI income_statement (quarterly, 2026-03-31) — Basic Average Shares: 139025000.00
SCI income_statement (quarterly, 2026-03-31) — Basic EPS: 0.98
SCI cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 246468000.00
SCI cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -108045000.00
SCI cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -79889000.00
SCI balance_sheet (quarterly, 2026-03-31) — Capital Stock: 138147000.00
SCI balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 257959000.00
SCI balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 257959000.00
SCI cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -47080000.00
SCI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -184909000.00
SCI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -132338000.00
SCI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 333793000.00
SCI cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 27713000.00
SCI cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 30661000.00
SCI cash_flow (quarterly, 2026-03-31) — Change In Payable: 33736000.00
SCI cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 33736000.00
SCI cash_flow (quarterly, 2026-03-31) — Change In Receivables: 8559000.00
SCI cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 100669000.00
SCI cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 8559000.00
SCI cash_flow (quarterly, 2026-03-31) — Changes In Cash: 16546000.00
SCI balance_sheet (quarterly, 2026-03-31) — Common Stock: 138147000.00
SCI balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 1584411000.00
SCI cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -143153000.00
SCI income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 810003000.00
SCI balance_sheet (quarterly, 2026-03-31) — Current Assets: 447742000.00
SCI balance_sheet (quarterly, 2026-03-31) — Current Debt: 57300000.00
SCI balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 57300000.00
SCI balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 790598000.00
SCI cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 7249000.00
SCI cash_flow (quarterly, 2026-03-31) — Deferred Tax: 7249000.00
SCI cash_flow (quarterly, 2026-03-31) — Depreciation: 79288000.00
SCI cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 82944000.00
SCI cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 82944000.00
SCI income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 139928000.00
SCI income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.97
SCI income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 135808000.00
SCI income_statement (quarterly, 2026-03-31) — EBIT: 245212000.00
SCI income_statement (quarterly, 2026-03-31) — EBITDA: 328156000.00
SCI cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -2045000.00
SCI cash_flow (quarterly, 2026-03-31) — End Cash Position: 260969000.00
SCI cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -184909000.00
SCI cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 225748000.00
SCI cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of Business: -1274000.00
SCI income_statement (quarterly, 2026-03-31) — Gain On Sale Of Ppe: 1274000.00
SCI balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 5309000.00
SCI income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 43911000.00
SCI balance_sheet (quarterly, 2026-03-31) — Goodwill: 2173354000.00
SCI balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 2173354000.00
SCI balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 103980000.00
SCI balance_sheet (quarterly, 2026-03-31) — Gross PPE: 5016725000.00
SCI income_statement (quarterly, 2026-03-31) — Gross Profit: 286451000.00
SCI balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 4805000.00
SCI income_statement (quarterly, 2026-03-31) — Interest Expense: 64006000.00
SCI income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 64006000.00
SCI balance_sheet (quarterly, 2026-03-31) — Inventory: 38414000.00
SCI balance_sheet (quarterly, 2026-03-31) — Invested Capital: 6747227000.00
SCI cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -132338000.00
SCI balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 8091022000.00
SCI cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 166082000.00
SCI balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 5105516000.00
SCI balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 5105516000.00
SCI cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 166082000.00
SCI cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -16614000.00
SCI balance_sheet (quarterly, 2026-03-31) — Minority Interest: 538000.00
SCI income_statement (quarterly, 2026-03-31) — Minority Interests: -65000.00
SCI cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -20358000.00
SCI cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -143153000.00
SCI balance_sheet (quarterly, 2026-03-31) — Net Debt: 4904857000.00
SCI income_statement (quarterly, 2026-03-31) — Net Income: 135808000.00
SCI income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 135808000.00
SCI income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 135873000.00
SCI income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 135808000.00
SCI income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 135808000.00
SCI cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 135873000.00
SCI income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 135873000.00
SCI income_statement (quarterly, 2026-03-31) — Net Interest Income: -64006000.00
SCI cash_flow (quarterly, 2026-03-31) — Net Investment Properties Purchase And Sale: -3839000.00
SCI cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 139295000.00
SCI cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 149468000.00
SCI income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -64006000.00
SCI cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -140000000.00
SCI cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -96000.00
SCI balance_sheet (quarterly, 2026-03-31) — Net PPE: 5016725000.00
SCI cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -28156000.00
SCI cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: -10173000.00
SCI balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -588943000.00
SCI balance_sheet (quarterly, 2026-03-31) — Non Current Accounts Receivable: 1538865000.00
SCI balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 8207126000.00
SCI balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 7508780000.00
SCI balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 698346000.00
SCI income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 326882000.00
SCI income_statement (quarterly, 2026-03-31) — Normalized Income: 134852721.47
SCI cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 333793000.00
SCI cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -1274000.00
SCI income_statement (quarterly, 2026-03-31) — Operating Income: 242540000.00
SCI income_statement (quarterly, 2026-03-31) — Operating Revenue: 989635000.00
SCI balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 138147494.00
SCI balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 28912000.00
SCI balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 5309000.00
SCI income_statement (quarterly, 2026-03-31) — Other Gand A: 43911000.00
SCI income_statement (quarterly, 2026-03-31) — Other Income Expense: 2672000.00
SCI balance_sheet (quarterly, 2026-03-31) — Other Investments: 8091022000.00
SCI cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 2226000.00
SCI balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 1307041000.00
SCI balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 2886560000.00
SCI income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 1398000.00
SCI balance_sheet (quarterly, 2026-03-31) — Other Properties: 5016725000.00
SCI balance_sheet (quarterly, 2026-03-31) — Payables: 733298000.00
SCI balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 733298000.00
SCI income_statement (quarterly, 2026-03-31) — Pretax Income: 181206000.00
SCI cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 6029000.00
SCI cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 1943000.00
SCI cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -24085000.00
SCI cash_flow (quarterly, 2026-03-31) — Purchase Of Investment Properties: -3839000.00
SCI cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -28156000.00
SCI balance_sheet (quarterly, 2026-03-31) — Receivables: 122457000.00
SCI income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 810003000.00
SCI income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 82944000.00
SCI cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -16614000.00
SCI cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -143153000.00
SCI balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 458980000.00
SCI cash_flow (quarterly, 2026-03-31) — Sale Of Business: 3727000.00
SCI income_statement (quarterly, 2026-03-31) — Selling General And Administration: 43911000.00
SCI balance_sheet (quarterly, 2026-03-31) — Share Issued: 142215508.00
SCI income_statement (quarterly, 2026-03-31) — Special Income Charges: 1274000.00
SCI cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 4163000.00
SCI balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 1584411000.00
SCI balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -588943000.00
SCI income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 318721.47
SCI income_statement (quarterly, 2026-03-31) — Tax Provision: 45333000.00
SCI income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.25
SCI balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 22202000.00
SCI balance_sheet (quarterly, 2026-03-31) — Total Assets: 18574749000.00
SCI balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 6689927000.00
SCI balance_sheet (quarterly, 2026-03-31) — Total Debt: 5162816000.00
SCI balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 1584949000.00
SCI income_statement (quarterly, 2026-03-31) — Total Expenses: 853914000.00
SCI balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 16989800000.00
SCI balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 18127007000.00
SCI balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 16199202000.00
SCI income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 243814000.00
SCI balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 4805000.00
SCI income_statement (quarterly, 2026-03-31) — Total Unusual Items: 1274000.00
SCI income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 1274000.00
SCI balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 4068014.00
SCI balance_sheet (quarterly, 2026-03-31) — Working Capital: -342856000.00
SCI income_statement (quarterly, 2026-03-31) — Write Off: 0.00
SCI.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -53914800000.00
SCI.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 5217700000.00
SCI.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -2466100000.00
SCI.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 4200000.00
SCI.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 465799010.00
SCI.NS income_statement (annual, 2022-03-31) — Basic EPS: 18.47
SCI.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 201300000.00
SCI.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 1937400000.00
SCI.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 893200000.00
SCI.NS cash_flow (annual, 2022-03-31) — Common Stock Dividend Paid: -116100000.00
SCI.NS balance_sheet (annual, 2022-03-31) — Defined Pension Benefit: 741800000.00
SCI.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 465799010.00
SCI.NS income_statement (annual, 2022-03-31) — Diluted EPS: 18.47
SCI.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 1000000.00
SCI.NS balance_sheet (annual, 2022-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 37300000.00
SCI.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 55800000.00
SCI.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 8839300000.00
SCI.NS income_statement (annual, 2022-03-31) — Impairment Of Capital Assets: 100000.00
SCI.NS income_statement (annual, 2022-03-31) — Interest Income: 667400000.00
SCI.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 667400000.00
SCI.NS balance_sheet (annual, 2022-03-31) — Investmentsin Joint Venturesat Cost: 4720400000.00
SCI.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 41900000.00
SCI.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 129911300000.00
SCI.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 686300000.00
SCI.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 182200000.00
SCI.NS balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 900000.00
SCI.NS balance_sheet (annual, 2022-03-31) — Other Non Current Liabilities: 2729900000.00
SCI.NS balance_sheet (annual, 2022-03-31) — Other Payable: 591700000.00
SCI.NS income_statement (annual, 2022-03-31) — Other Special Charges: -396500000.00
SCI.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 1871800000.00
SCI.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 1119400000.00
SCI.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
SCI.NS cash_flow (annual, 2022-03-31) — Purchase Of Investment: -2965800000.00
SCI.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 800000.00
SCI.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 3521300000.00
SCI.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 207900000.00
SCI.NS income_statement (annual, 2022-03-31) — Restructuring And Mergern Acquisition: 2400000.00
SCI.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: -2122600000.00
SCI.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 4000000.00
SCI.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 59800000.00
SCI.NS balance_sheet (annual, 2022-03-31) — Taxes Receivable: 752600000.00
SCI.NS income_statement (annual, 2022-03-31) — Total Expenses: 40518200000.00
SCI.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 30400000.00
SCI.NS income_statement (annual, 2022-03-31) — Write Off: 3100000.00
SCI.NS income_statement (annual, 2023-03-31) — +Operating Expense: 1094000000.00
SCI.NS income_statement (annual, 2023-03-31) — +Total Revenue: 57704200000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 13930200000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 10181500000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -57857700000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 5217700000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -3155500000.00
SCI.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 900000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Assets Held For Sale Current: 0.00
SCI.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 700000.00
SCI.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 465799010.00
SCI.NS income_statement (annual, 2023-03-31) — Basic EPS: 18.68
SCI.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 2830600000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 201300000.00
SCI.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -4758100000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 216400000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 4658000000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 3168200000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 7053900000.00
SCI.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -153200000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 2448800000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 719400000.00
SCI.NS cash_flow (annual, 2023-03-31) — Change In Inventory: 248100000.00
SCI.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -627400000.00
SCI.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 1036500000.00
SCI.NS cash_flow (annual, 2023-03-31) — Change In Payable: 1795800000.00
SCI.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -3824200000.00
SCI.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -1371200000.00
SCI.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 161100000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Common Stock: 4658000000.00
SCI.NS cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -153200000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 69023300000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 335100000.00
SCI.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 46579400000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Current Assets: 26903700000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 20400000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Current Debt: 9237900000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 9258300000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 27921500000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 166300000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Defined Pension Benefit: 842300000.00
SCI.NS cash_flow (annual, 2023-03-31) — Depreciation: 7530700000.00
SCI.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 7531600000.00
SCI.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 465799010.00
SCI.NS income_statement (annual, 2023-03-31) — Diluted EPS: 18.68
SCI.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 8701600000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 1500000.00
SCI.NS cash_flow (annual, 2023-03-31) — Dividends Received Cfi: 147800000.00
SCI.NS income_statement (annual, 2023-03-31) — EBIT: 9224400000.00
SCI.NS income_statement (annual, 2023-03-31) — EBITDA: 16756000000.00
SCI.NS cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: 182800000.00
SCI.NS cash_flow (annual, 2023-03-31) — End Cash Position: 3174500000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 43400000.00
SCI.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -9299400000.00
SCI.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 9896200000.00
SCI.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -210500000.00
SCI.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 200000.00
SCI.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 56700000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 0.00
SCI.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 13337000000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 132226400000.00
SCI.NS income_statement (annual, 2023-03-31) — Gross Profit: 11124800000.00
SCI.NS income_statement (annual, 2023-03-31) — Impairment Of Capital Assets: 0.00
SCI.NS income_statement (annual, 2023-03-31) — Interest Expense: 1194200000.00
SCI.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 1194200000.00
SCI.NS income_statement (annual, 2023-03-31) — Interest Income: 467700000.00
SCI.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 467700000.00
SCI.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -1088700000.00
SCI.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 608900000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Inventory: 1500100000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 94852700000.00
SCI.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -5193800000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 44100000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Investmentsin Joint Venturesat Cost: 6064100000.00
SCI.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 0.00
SCI.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 41900000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 196000000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 16591500000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 16787500000.00
SCI.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 0.00
SCI.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -6055600000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 6064100000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 673300000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 131648100000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Net Debt: 22661200000.00
SCI.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 695800000.00
SCI.NS income_statement (annual, 2023-03-31) — Net Income: 8701600000.00
SCI.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 8701600000.00
SCI.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 8701600000.00
SCI.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 8701600000.00
SCI.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 8701600000.00
SCI.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 8030200000.00
SCI.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 8701600000.00
SCI.NS income_statement (annual, 2023-03-31) — Net Interest Income: -747000000.00
SCI.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -1227700000.00
SCI.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -8005300000.00
SCI.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -6055600000.00
SCI.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -747000000.00
SCI.NS cash_flow (annual, 2023-03-31) — Net Other Financing Charges: -35700000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Net PPE: 74368700000.00
SCI.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -4758100000.00
SCI.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: -1949700000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 69023300000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 0.00
SCI.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 9800000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 673300000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 185900000.00
SCI.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 16540500000.00
SCI.NS income_statement (annual, 2023-03-31) — Normalized Income: 8550750000.00
SCI.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 14654300000.00
SCI.NS income_statement (annual, 2023-03-31) — Operating Income: 10030800000.00
SCI.NS income_statement (annual, 2023-03-31) — Operating Revenue: 57704200000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 465799010.00
SCI.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 22200000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 542000000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 59056400000.00
SCI.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 738900000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 75600000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 700000.00
SCI.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 2800000.00
SCI.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 970100000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Other Payable: 551100000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Other Properties: 74033600000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 5771800000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 3885700000.00
SCI.NS income_statement (annual, 2023-03-31) — Other Special Charges: -198300000.00
SCI.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
SCI.NS balance_sheet (annual, 2023-03-31) — Payables: 14482800000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 2051900000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 1465000000.00
SCI.NS income_statement (annual, 2023-03-31) — Pretax Income: 8030200000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
SCI.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 387800000.00
SCI.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -1284200000.00
SCI.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -4758100000.00
SCI.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 46579400000.00
SCI.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 7531600000.00
SCI.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 2900000.00
SCI.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 1341000000.00
SCI.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -6055600000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 167900000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 5108600000.00
SCI.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 56500000.00
SCI.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 0.00
SCI.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 5800000.00
SCI.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 62500000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Share Issued: 465799010.00
SCI.NS income_statement (annual, 2023-03-31) — Special Income Charges: 152900000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 69023300000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 69023300000.00
SCI.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 64650000.00
SCI.NS income_statement (annual, 2023-03-31) — Tax Provision: -671400000.00
SCI.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.30
SCI.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 741300000.00
SCI.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -498700000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Total Assets: 114429800000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 85614800000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Total Debt: 26045800000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 69023300000.00
SCI.NS income_statement (annual, 2023-03-31) — Total Expenses: 47673400000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 45406500000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 87526100000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 17485000000.00
SCI.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 20500000.00
SCI.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 215500000.00
SCI.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 215500000.00
SCI.NS balance_sheet (annual, 2023-03-31) — Working Capital: -1017800000.00
SCI.NS income_statement (annual, 2023-03-31) — Write Off: 45400000.00
SCI.NS income_statement (annual, 2024-03-31) — +Operating Expense: 1273500000.00
SCI.NS income_statement (annual, 2024-03-31) — +Total Revenue: 50320200000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 13354600000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 14109000000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -60703900000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 5217700000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -3387900000.00
SCI.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 300000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Assets Held For Sale Current: 0.00
SCI.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 9300000.00
SCI.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 465799010.00
SCI.NS income_statement (annual, 2024-03-31) — Basic EPS: 14.58
SCI.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 3174500000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 194400000.00
SCI.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -5117700000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 208500000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 4658000000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 8383900000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 11886000000.00
SCI.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -204300000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 7998200000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 385700000.00
SCI.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -241100000.00
SCI.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: 2010000000.00
SCI.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: -2611300000.00
SCI.NS cash_flow (annual, 2024-03-31) — Change In Payable: -260000000.00
SCI.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -4519500000.00
SCI.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -5621900000.00
SCI.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 5381300000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Common Stock: 4658000000.00
SCI.NS cash_flow (annual, 2024-03-31) — Common Stock Dividend Paid: -204300000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 75395000000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 421300000.00
SCI.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 43406500000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Current Assets: 36206600000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 26100000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Current Debt: 13277800000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 13303900000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 29162100000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 102400000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Defined Pension Benefit: 924800000.00
SCI.NS cash_flow (annual, 2024-03-31) — Depreciation: 8893500000.00
SCI.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 8893800000.00
SCI.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 465799010.00
SCI.NS income_statement (annual, 2024-03-31) — Diluted EPS: 14.58
SCI.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 6789700000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 2200000.00
SCI.NS cash_flow (annual, 2024-03-31) — Dividends Received Cfi: 449400000.00
SCI.NS income_statement (annual, 2024-03-31) — EBIT: 7989500000.00
SCI.NS income_statement (annual, 2024-03-31) — EBITDA: 16883300000.00
SCI.NS cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: -139600000.00
SCI.NS cash_flow (annual, 2024-03-31) — End Cash Position: 8416200000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 48200000.00
SCI.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: 1032000000.00
SCI.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 4822900000.00
SCI.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -491600000.00
SCI.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -462900000.00
SCI.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 49000000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 3200000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 17496900000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 131321500000.00
SCI.NS income_statement (annual, 2024-03-31) — Gross Profit: 6913700000.00
SCI.NS income_statement (annual, 2024-03-31) — Impairment Of Capital Assets: 0.00
SCI.NS income_statement (annual, 2024-03-31) — Interest Expense: 1536500000.00
SCI.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 1536500000.00
SCI.NS income_statement (annual, 2024-03-31) — Interest Income: 831100000.00
SCI.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 831100000.00
SCI.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -1531600000.00
SCI.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 869800000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Inventory: 1741200000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 104328700000.00
SCI.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -5591300000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 57500000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Investmentsin Joint Venturesat Cost: 6523700000.00
SCI.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 9406500000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 41900000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 182400000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 15655900000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 15838300000.00
SCI.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 9406500000.00
SCI.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -6694700000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 6523700000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 574200000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 130663900000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Net Debt: 20549800000.00
SCI.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: 137800000.00
SCI.NS income_statement (annual, 2024-03-31) — Net Income: 6789700000.00
SCI.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 6789700000.00
SCI.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 6789700000.00
SCI.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 6789700000.00
SCI.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 6789700000.00
SCI.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 6453000000.00
SCI.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 6789700000.00
SCI.NS income_statement (annual, 2024-03-31) — Net Interest Income: -725300000.00
SCI.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -2337800000.00
SCI.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 2815900000.00
SCI.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 2711800000.00
SCI.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -725300000.00
SCI.NS cash_flow (annual, 2024-03-31) — Net Other Financing Charges: -30400000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Net PPE: 70617600000.00
SCI.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -4475900000.00
SCI.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: 104100000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 75391800000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 0.00
SCI.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 10900000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 574200000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 217600000.00
SCI.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 16253300000.00
SCI.NS income_statement (annual, 2024-03-31) — Normalized Income: 6348700000.00
SCI.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 9940600000.00
SCI.NS income_statement (annual, 2024-03-31) — Operating Income: 5640200000.00
SCI.NS income_statement (annual, 2024-03-31) — Operating Revenue: 50320200000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 465799010.00
SCI.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 47500000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 85700000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 70737000000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 3200000.00
SCI.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 887700000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: -88500000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 700000.00
SCI.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 4400000.00
SCI.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 1389200000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Other Payable: 512900000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Other Properties: 70034700000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 4787300000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 3502100000.00
SCI.NS income_statement (annual, 2024-03-31) — Other Special Charges: -588100000.00
SCI.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
SCI.NS balance_sheet (annual, 2024-03-31) — Payables: 13869700000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 1014600000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 1804500000.00
SCI.NS income_statement (annual, 2024-03-31) — Pretax Income: 6453000000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
SCI.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 656600000.00
SCI.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -2375200000.00
SCI.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -5117700000.00
SCI.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 43406500000.00
SCI.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 8893800000.00
SCI.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 37600000.00
SCI.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 1179000000.00
SCI.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -6694700000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 1257300000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 10943600000.00
SCI.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 37400000.00
SCI.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 641800000.00
SCI.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 15200000.00
SCI.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 64200000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Share Issued: 465799010.00
SCI.NS income_statement (annual, 2024-03-31) — Special Income Charges: 587800000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 75395000000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 75391800000.00
SCI.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 189000000.00
SCI.NS income_statement (annual, 2024-03-31) — Tax Provision: -336700000.00
SCI.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.30
SCI.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 573800000.00
SCI.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: 162200000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Total Assets: 120999000000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 91050900000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Total Debt: 29142200000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 75395000000.00
SCI.NS income_statement (annual, 2024-03-31) — Total Expenses: 44680000000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 45604000000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 84510400000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 16441900000.00
SCI.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 19900000.00
SCI.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 630000000.00
SCI.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 630000000.00
SCI.NS balance_sheet (annual, 2024-03-31) — Treasury Shares Number: 0.00
SCI.NS balance_sheet (annual, 2024-03-31) — Working Capital: 7044500000.00
SCI.NS income_statement (annual, 2024-03-31) — Write Off: 300000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 9389700000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 14725800000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Assets Held For Sale Current: 0.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 176300000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 3395800000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 4658000000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 2429900000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 12944300000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 4658000000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 80606300000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 91700000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 31865100000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 1061500000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 5041000000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 6102500000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 18155800000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 92700000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 3700000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 71060900000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 1935400000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 100891600000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 176300000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 2334300000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 15244300000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 17578600000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Long Term Equity Investment: 6257300000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 584500000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 17855400000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 71060900000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 80602600000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 0.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 10900000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 465799010.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 2235100000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 904100000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 75948300000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 3700000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 1670200000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 800000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 70969200000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Other Receivables: 24500000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 10514400000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Payables: 9389700000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 465799010.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 80606300000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 80602600000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 116953900000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 95850600000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 23681100000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 80606300000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 36347600000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 85088800000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 18191800000.00
SCI.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 13709300000.00